Efficacy and Accuracy of Combined Localization Versus Single Localization in Non-palpable Breast Cancer After Neo-adjuvant Therapy : a Prospective Randomized Control Trial.
Status: Recruiting
Location: See location...
Intervention Type: Procedure
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY
The standard method for localizing non-palpable breast cancer is currently clip localization, its positive margin rate still remains around 20-50%. This study aims to compare the accuracy and efficacy of single vs. combined breast tissue markers in localizing non-palpable breast cancer.
Eligibility
Participation Requirements
Sex: Female
Minimum Age: 18
Healthy Volunteers: f
View:
• female patients, age≥18 year
• A score of ≥ 2 on the Eastern Cooperative Oncology Group scale
• Patients pathologically diagnosed with breast cancer by core-needle biopsy, received neoadjuvant treatment and the lesion becomes non-palpable before enrollment.
• Patients are willing to undergo breast conserving surgery and have no contraindications to breast conserving surgery
Locations
Other Locations
China
Sun Yat-sen University Sun Yat-sen Memorial Hospital
RECRUITING
Guangzhou
Contact Information
Primary
Chang Gong, doctor
changgong282@163.com
02034070499
Time Frame
Start Date: 2023-02-16
Estimated Completion Date: 2025-12-01
Participants
Target number of participants: 110
Treatments
Experimental: patients after neoadjuvant therapy-combined localization
Active_comparator: patients after neoadjuvant therapy-single localization
Related Therapeutic Areas
Sponsors
Leads: Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University